Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

22.03
-1.5100-6.41%
Post-market: 22.170.1400+0.64%19:55 EDT
Volume:1.55M
Turnover:35.06M
Market Cap:1.31B
PE:-9.17
High:23.96
Open:23.63
Low:21.86
Close:23.54
52wk High:40.65
52wk Low:11.82
Shares:59.49M
Float Shares:35.21M
Volume Ratio:0.64
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:3.71
PE(LYR):-10.95

Loading ...

Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Correspondence

Form CORRESP - Correspondence
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities